167357-55-3

Usage

Uses

Used in Pharmaceutical Industry:
(+)-2(S)-(phenylmethyloxymethyl)morpholine is used as a chiral building block for the synthesis of various drugs with therapeutic properties. Its ability to introduce chirality into organic compounds makes it a valuable tool in drug discovery and development.
Used in Organic Synthesis:
(+)-2(S)-(phenylmethyloxymethyl)morpholine is used as a reagent in the preparation of chiral intermediates and natural products, contributing to the advancement of organic chemistry and the creation of enantioselective synthetic routes.

Upstream product

• 2930-05-4 Benzyloxymethyl-oxiran 
• 926-39-6 sulfuric acid mono-(2-amino-ethyl ester) 
• 2930-05-4 (S)-benzyl glycidyl ether 

Downstream Products

• 911223-10-4 (S)-2-benzyloxymethyl-morpholine-4-carboxylic acid tert-butyl ester 
• 135065-76-8 tert-butyl (2S)-2-(hydroxymethyl)morpholine-4-carboxylate 

Relevant academic research and scientific papers

BENZAMIDE DERIVATIVES, THEIR PREPARATION AND USES IN MEDICINE THEREOF

The present invention discloses novel benzamide derivatives represented by general formula (I), their preparation, pharmaceutical compositions containing the derivatives and their use as medicament, especially as a 5-HT4 stimulator, wherein the

BENZAMIDE DERIVATIVES, THEIR PREPARATION AND USES IN MEDICINE THEREOF

The present invention discloses novel benzamide derivatives represented by general formula (I), their preparation, pharmaceutical compositions containing the derivatives and their use as medicament, especially as a 5-HT4 stimulator, wherein the

CYSTEINE PROTEASE INHIBITORS

Stereoisomers of the formula (III) wherein R is H or C1-C3 optionally halo-substituted alkyl; or pharmaceutically acceptable salts, hydrates or N-oxides thereof have utility in the treatment of disorders mediated by inappropriate exp

HETEROARYL UREA DERIVATIVES USEFUL FOR INHIBITING CHKl

Substituted urea compounds useful in the treatment of diseases and conditions related to DNA damage or lesions in DNA replication are disclosed. Methods of making the compounds, and their use as therapeutic agents, for example, in treating cancer and other diseases characterized by defects in DNA replication, chromosome segregation, or cell division, also are disclosed.

MORPHOLINE DERIVATIVES AS DOPAMINE RECEPTOR SUBTYPE LIGANDS

A class of substituted morpholine derivatives of formula STR1 wherein Y represents an optionally substituted bicyclic heteroaromatic ring system containing one or two nitrogen atoms, the ring system comprising a six-membered aromatic or heteroaromatic ring fused to a five-or six-membered heteroaromatic ring; and Z represents an optionally substituted arylalkyl, aryloxymethyl or arylalkoxymethyl group, are ligands for dopamine receptor subtypes within the body and are therefore useful in the treatment and/or prevention of disorders of the dopamine system, in particular schizophrenia.